 ACADIA Pharmaceuticals Inc. NASDAQ: ACAD, Bio-Path Holdings, Inc. NASDAQ: BPTH and Cidara Therapeutics, Inc. NASDAQ: CDTX are among the early movers in the biotech space. ACADIA Wilts On FDA Rejection: Acadia said the FDA has issued a complete response letter regarding its supplemental new drug application for Nuplazid for the treatment of hallucinations and delusions associated with dementia-related psychosis. 